Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
11.75
+0.66 (5.95%)
Aug 4, 2025, 4:00 PM - Market closed
Accolade Market Cap
Greenwich LifeSciences has a market cap or net worth of $159.62 million as of August 4, 2025. Its market cap has decreased by -20.20% in one year.
Market Cap
159.62M
Enterprise Value
156.87M
1-Year Change
-20.20%
Ranking
Category
Stock Price
$11.75
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $159.62M, an increase of 132.38%. That is a compound annual growth rate of 18.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 159.62M | 8.13% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | 463.30M | 574.50% |
| Sep 25, 2020 | 68.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 690.36B |
| Johnson & Johnson | 411.92B |
| AbbVie | 348.32B |
| AstraZeneca | 229.32B |
| Novartis AG | 226.38B |
| Abbott Laboratories | 226.14B |
| UnitedHealth Group | 218.60B |
| Novo Nordisk | 215.34B |